US 10071083
Use of gaboxadol in the treatment of tinnitus
granted A61KA61K2300/00A61K31/437
Quick answer
US patent 10071083 (Use of gaboxadol in the treatment of tinnitus) held by OVID THERAPEUTICS INC. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2300/00, A61K31/437, A61K31/5513, A61P